Accelerate Diagnostics Stock (NASDAQ:AXDX)



Previous Close

$1.18

52W Range

$0.73 - $2.09

50D Avg

$1.25

200D Avg

$1.42

Market Cap

$29.30M

Avg Vol (3M)

$56.93K

Beta

0.61

Div Yield

-

AXDX Company Profile


Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

134

IPO Date

Apr 07, 1994

Website

AXDX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Service$1.45M$1.65M$1.35M
Other Revenue$131.00K$154.00K$154.00K
Product$10.61M$11.11M$10.43M
Accelerate Pheno-$12.60M$11.63M

Fiscal year ends in Dec 23 | Currency in USD

AXDX Financial Summary


Dec 23Dec 22Dec 21
Revenue$12.06M$12.75M$11.78M
Operating Income$-54.03M$-62.80M$-71.56M
Net Income$-61.62M$-62.49M$-77.70M
EBITDA$-54.03M$-59.48M$-68.97M
Basic EPS$-4.94$-7.61$-12.60
Diluted EPS$-4.94$-7.61$-12.59

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 08, 24 | 4:30 PM
Q2 24Aug 10, 24 | 4:30 PM
Q1 24May 08, 24 | 4:30 PM

Peer Comparison


TickerCompany
AXGNAxoGen, Inc.
LUNGPulmonx Corporation
KIDSOrthoPediatrics Corp.
CNMDCONMED Corporation
SGHTSight Sciences, Inc.
NPCENeuroPace, Inc.
AORTArtivion, Inc.
LIVNLivaNova PLC
AVNSAvanos Medical, Inc.
IRMDIRadimed Corporation
SRDXSurmodics, Inc.
ITGRInteger Holdings Corporation
ANIKAnika Therapeutics, Inc.
OFIXOrthofix Medical Inc.
CVRXCVRx, Inc.